Figure 3.

Progression of radiographic Sharp scores (mean ± SD) after five years in patients with or without anti-CCP2 antibodies, according to the change in anti-CCP2 concentrations between baseline and three years.

Meyer et al. Arthritis Research & Therapy 2006 8:R40   doi:10.1186/ar1896
Download authors' original image